North Sichuan Medical College, Nanchong, Sichuan Province, China.
Hepatobiliary Surgery, The third Hospital of Mianyang·Sichuan Mental Health Center, Mianyang, Sichuan Province, China.
BMC Gastroenterol. 2020 Jul 17;20(1):229. doi: 10.1186/s12876-020-01376-y.
Endoscopic sphincterotomy (ES) is the standard treatment for common bile duct stones. The reported findings regarding complications, such as biliary pancreatitis and cholangitis, differ between cholecystectomy after ES. The purpose of this study is to compare cholecystectomy outcomes after endoscopic treatment of common bile duct stones whether or not the incidence of recurrent pancreatitis and cholangitis is reduced, especially in high-risk patients.
We analyzed 8 studies, including 7 randomized controlled trials retrieved from the PubMed (1990-2019), Embase (1990-2019), and Cochrane (1990-2019) databases for trials comparing the two strategies for treatment of gallstones after ES. A related study on gallbladder removal after ES was acquired, followed by analysis of each group using RevMan. Risk ratios (RRs) were calculated for categorical variables and differences in means were calculated for continuous variables.
We retrieved a total of 8 studies, including seven randomized controlled trials and one retrospective study. A total of 12,717 patients were included in the study (4922 in the early cholecystectomy group and 7795 in the gallbladder in situ group). During the follow-up period, 41 patients had pancreatitis after ES in the cholecystectomy group and 177 patients in the wait-and-see group. The incidence of pancreatitis in the cholecystectomy group was significantly reduced (RR, 0.38; 95% CI, 0.27-0.53; P < 0.00001; I = 0%). The incidence of cholangitis and jaundice in the cholecystectomy group was also less than the preserved gallbladder group (RR, 0.31; 95% CI, 0.26-0.38; P < 0.00001; I = 0%). There was no significant difference in mortality between the two groups (RR, 0.73; 95% CI, 0.52-1.02; P = 0.07; I = 14%). There was a significant difference in cholecystitis and biliary colic (RR, 0.28; 95% CI, 0.24-0.32; P < 0.00001; I = 17%).
Early cholecystectomy after removal of common bile duct stones can effectively reduce biliary complications. This is still true for high-risk patients and has no significant effect on the mortality of patients. Laparoscopic cholecystectomy is recommended after ES.
内镜下括约肌切开术(ES)是治疗胆总管结石的标准方法。关于 ES 后行胆囊切除术的并发症(如胆源性胰腺炎和胆管炎)的报道结果存在差异。本研究旨在比较内镜治疗胆总管结石后行胆囊切除术的结果,特别是在高危患者中,是否能降低复发性胰腺炎和胆管炎的发生率。
我们分析了从 PubMed(1990-2019 年)、Embase(1990-2019 年)和 Cochrane(1990-2019 年)数据库中检索到的 8 项研究,这些研究均为比较 ES 后两种治疗胆囊结石策略的随机对照试验。获取了一项关于 ES 后行胆囊切除术的相关研究,并对每组数据进行 RevMan 分析。对分类变量计算比值比(RR),对连续变量计算均数差。
我们共检索到 8 项研究,其中 7 项为随机对照试验,1 项为回顾性研究。共有 12717 名患者纳入研究(早期胆囊切除术组 4922 例,原位胆囊保留组 7795 例)。在随访期间,ES 后行胆囊切除术组有 41 例发生胰腺炎,而等待观察组有 177 例。胆囊切除术组胰腺炎的发生率显著降低(RR,0.38;95%CI,0.27-0.53;P<0.00001;I²=0%)。胆囊切除术组胆管炎和黄疸的发生率也低于原位胆囊保留组(RR,0.31;95%CI,0.26-0.38;P<0.00001;I²=0%)。两组死亡率无显著差异(RR,0.73;95%CI,0.52-1.02;P=0.07;I²=14%)。但两组胆囊炎和胆绞痛的发生率有显著差异(RR,0.28;95%CI,0.24-0.32;P<0.00001;I²=17%)。
胆总管结石取出后早期行胆囊切除术可有效降低胆道并发症。这在高危患者中仍然适用,且对患者死亡率无显著影响。建议 ES 后行腹腔镜胆囊切除术。